Hidden mutations in immune cells linked to autoimmune disease
On Apr. 14, 2026, researchers from the Wellcome Sanger Institute, Cambridge University Hospitals NHS Foundation Trust (CUH), the…
-
-
Beam Therapeutics Announces Positive Data in Trial Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
-
New mutation linked to early-onset Parkinsonism
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
-
Biotechnology | Disease | FDA | Therapeutics
Vertex announced U.S. FDA approval for TRIKAFTA in children with cystic fibrosis ages 2 through 5 with certain mutations
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
-
U.S. FDA approved treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene
On Apr. 25, 2023, the U.S. U.S. Food and Drug Administration (FDA announced it had approved Qalsody (tofersen) to…
-
Biotechnology | Diagnostics | NIH | Oncology | Radiology
Blood test identified acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant
On Mar. 7, 2023, researchers at the National Institutes of Health reported the benefits of screening adult patients…
-
Biotechnology | COVID-19 | Diagnostics | Measles | Medical Device | Vaccine
Roche launched SARS-CoV-2 variant test to help monitor emerging coronavirus mutations
On Mar. 16, 2021, Roche announced the launch of the cobas SARS-CoV-2 Variant Set 1 Test to detect…
-
PerkinElmer launched comprehensive solutions for detecting SARS-CoV-2 mutations
On Mar. 9, 2021, PerkinElmer announced the launch of the PerkinElmer COVID-19 Antigen Test for the qualitative detection…
